Counting the costs of ankylosing spondylitis

Ankylosing spondylitis (AS) is a chronic rheumatic disease. A debilitating condition, it has large patient and societal burdens. However, the financial impact of the disease is not fully understood. Aiming to change this are Dr Jessica Walsh from the University of Utah School of Medicine, Drs Xue Song and Gilwan Kim from IBM Watson Health, and Dr Yujin Park from Novartis […]

Read More…